Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Claudin 1 Is Highly Upregulated by PKC in MCF7 Human Breast Cancer Cells and Correlates Positively with PKCε in Patient Biopsies.

Blanchard AA, Ma X, Wang N, Hombach-Klonisch S, Penner C, Ozturk A, Klonisch T, Pitz M, Murphy L, Leygue E, Myal Y.

Transl Oncol. 2019 Mar;12(3):561-575. doi: 10.1016/j.tranon.2018.12.011. Epub 2019 Jan 15.

2.

Population-based analysis of breast cancer treatment by intrinsic sub-type in Manitoba, Canada.

Hammond E, Shu E, Sawchuk K, Myal Y, Raouf A, Klonisch T, Hombach-Klonisch S, Leygue E, Kung S, Safneck J, Mowat M, Xu W, Murphy L, Pitz M.

Cancer Epidemiol. 2016 Dec;45:82-90. doi: 10.1016/j.canep.2016.10.006. Epub 2016 Oct 19.

PMID:
27770672
3.

Identification of Claudin 1 Transcript Variants in Human Invasive Breast Cancer.

Blanchard AA, Zelinski T, Xie J, Cooper S, Penner C, Leygue E, Myal Y.

PLoS One. 2016 Sep 20;11(9):e0163387. doi: 10.1371/journal.pone.0163387. eCollection 2016.

4.

Idiopathic Hypogonadotropic Hypogonadism Caused by Inactivating Mutations in SRA1.

Kotan LD, Cooper C, Darcan Ş, Carr IM, Özen S, Yan Y, Hamedani MK, Gürbüz F, Mengen E, Turan İ, Ulubay A, Akkuş G, Yüksel B, Topaloğlu AK, Leygue E.

J Clin Res Pediatr Endocrinol. 2016 Jun 5;8(2):125-34. doi: 10.4274/jcrpe.3248. Epub 2016 Apr 18.

5.

Dynamic Histone Acetylation of H3K4me3 Nucleosome Regulates MCL1 Pre-mRNA Splicing.

Khan DH, Gonzalez C, Tailor N, Hamedani MK, Leygue E, Davie JR.

J Cell Physiol. 2016 Oct;231(10):2196-204. doi: 10.1002/jcp.25337. Epub 2016 Mar 6.

PMID:
26864447
6.

Claudin 1 in Breast Cancer: New Insights.

Zhou B, Moodie A, Blanchard AA, Leygue E, Myal Y.

J Clin Med. 2015 Nov 27;4(12):1960-76. doi: 10.3390/jcm4121952. Review.

7.

The steroid receptor RNA activator protein (SRAP) controls cancer cell migration/motility.

Yan Y, Cooper C, Hamedani MK, Guppy B, Xu W, Tsuyuki D, Zhang C, Nugent Z, Blanchard A, Davie JR, McManus K, Murphy LC, Myal Y, Leygue E.

FEBS Lett. 2015 Dec 21;589(24 Pt B):4010-8. doi: 10.1016/j.febslet.2015.11.007. Epub 2015 Nov 17.

8.

PDK2-mediated alternative splicing switches Bnip3 from cell death to cell survival.

Gang H, Dhingra R, Lin J, Hai Y, Aviv Y, Margulets V, Hamedani M, Thanasupawat T, Leygue E, Klonisch T, Davie JR, Kirshenbaum LA.

J Cell Biol. 2015 Sep 28;210(7):1101-15. doi: 10.1083/jcb.201504047.

9.

Claudin 1 promotes migration and increases sensitivity to tamoxifen and anticancer drugs in luminal-like human breast cancer cells MCF7.

Zhou B, Blanchard A, Wang N, Ma X, Han J, Schroedter I, Leygue E, Myal Y.

Cancer Invest. 2015;33(9):429-39. doi: 10.3109/07357907.2015.1060996. Epub 2015 Aug 17.

PMID:
26288115
10.

Claudin 1 Promotes Migration and Increases Sensitivity to Tamoxifen and Anticancer Drugs in Luminal-like Human Breast Cancer Cells MCF7.

Zhou B, Blanchard A, Wang N, Ma X, Han J, Schroedter I, Leygue E, Myal Y.

Cancer Invest. 2015 Aug 17. [Epub ahead of print]

PMID:
26279089
11.

Towards further defining the proteome of mouse saliva.

Blanchard AA, Ezzati P, Shamshurin D, Nistor AC, Leygue E, Wilkins JA, Myal Y.

Proteome Sci. 2015 Feb 25;13:10. doi: 10.1186/s12953-015-0068-3. eCollection 2015.

12.

RNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing.

Khan DH, Gonzalez C, Cooper C, Sun JM, Chen HY, Healy S, Xu W, Smith KT, Workman JL, Leygue E, Davie JR.

Nucleic Acids Res. 2014 Feb;42(3):1656-70. doi: 10.1093/nar/gkt1134. Epub 2013 Nov 14.

13.

Steroid receptor RNA activator protein (SRAP) expression as a prognostic factor in ER+ human breast tumors.

Yan Y, Penner CC, Skliris GP, Cooper C, Nugent Z, Blanchard A, Hamedani MK, Wang X, Myal Y, Murphy LC, Leygue E.

J Cancer Res Clin Oncol. 2013 Oct;139(10):1637-47. doi: 10.1007/s00432-013-1485-2. Epub 2013 Aug 2.

PMID:
23907597
14.

Claudin 1 expression in basal-like breast cancer is related to patient age.

Blanchard AA, Ma X, Dueck KJ, Penner C, Cooper SC, Mulhall D, Murphy LC, Leygue E, Myal Y.

BMC Cancer. 2013 May 30;13:268. doi: 10.1186/1471-2407-13-268.

15.

A bi-faceted role of estrogen receptor β in breast cancer.

Leygue E, Murphy LC.

Endocr Relat Cancer. 2013 May 30;20(3):R127-39. doi: 10.1530/ERC-12-0389. Print 2013 Jun. Review.

PMID:
23533249
16.

The role of estrogen receptor-β in breast cancer.

Murphy LC, Leygue E.

Semin Reprod Med. 2012 Jan;30(1):5-13. doi: 10.1055/s-0031-1299592. Epub 2012 Jan 23. Review.

PMID:
22271289
17.

Steroid Receptor RNA Activator bi-faceted genetic system: Heads or Tails?

Cooper C, Vincett D, Yan Y, Hamedani MK, Myal Y, Leygue E.

Biochimie. 2011 Nov;93(11):1973-80. doi: 10.1016/j.biochi.2011.07.002. Epub 2011 Jul 12. Review.

PMID:
21771633
18.

Comparative evaluation of ERα and ERβ significance in breast cancer: state of the art.

Leygue E, Murphy L.

Expert Rev Endocrinol Metab. 2011 May;6(3):333-343. doi: 10.1586/eem.11.27.

PMID:
30754114
19.

A novel hypoxia-inducible spliced variant of mitochondrial death gene Bnip3 promotes survival of ventricular myocytes.

Gang H, Hai Y, Dhingra R, Gordon JW, Yurkova N, Aviv Y, Li H, Aguilar F, Marshall A, Leygue E, Kirshenbaum LA.

Circ Res. 2011 Apr 29;108(9):1084-92. doi: 10.1161/CIRCRESAHA.110.238709. Epub 2011 Mar 17.

PMID:
21415393
20.

Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers.

Myal Y, Leygue E, Blanchard AA.

J Biomed Biotechnol. 2010;2010:956897. doi: 10.1155/2010/956897. Epub 2010 May 13.

Supplemental Content

Loading ...
Support Center